Seasonal allergic hay fever due to grass or tree pollen in patients who have failed to respond to anti-allergy drugs
Adult and child over 5 years, 1 tablet daily; start treatment at least 4 months before start of pollen season
Treatment with Grazax® will not be continued longer than 3 years.
NICE TA431 Mepolizumab, as an add-on to optimised standard therapy, is recommended as an option for treating severe refractory eosinophilic asthma in adults (January 2017). Commissioned by NHS England.
Injection 150mg/ml pre-filled syringe 0.5ml, 1ml
NICE TA278 Omalizumab is recommended for severe persistent allergic asthma (April 2013)
NICE TA339 Omalizumab is recommended for previously treated chronic spontaneous urticaria (June 2015). Commissioned by NHS England.